Health Condition 1: H508- Other specified strabismus
Conditions
Interventions
Intervention1: group 1 Injection group: subtenon injection Ropivacaine 0.5 percent will be given
study period -18 months
Control Intervention1: group 2 Control group: no subtenon injection will be giv
Sponsors
Dr,Kriti Khurana
Eligibility
Inclusion criteria
Inclusion criteria: Patients with comitant strabismus ASA physical status 1 or 2 scheduled for elective strabismus surgery
Exclusion criteria
Exclusion criteria: Inability of parents to understand the consent process Children with suspected allergy to the drugs employed Children with preexisting cardiac or neurological disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the efficacy of subtenon ropivacaine 0.5 percent injection in reducing the incidence of intraoperative oculocardiac reflex in paediatric patients undergoing strabismus surgery under general anesthesiaTimepoint: 1.5 years | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate fluctuations in non-invasive blood pressure (NIBP) during surgeryTimepoint: 1.5 years;To identify and compare the occurrence of ECG abnormalities between the two groups.Timepoint: 1.5 years;To compare the severity of postoperative pain.Timepoint: 1.5 years;To assess the incidence of postoperative nausea and vomiting (PONV) in both groupsTimepoint: 1.5 years;To assess variations in peripheral oxygen saturation (SpO2) associated with the oculocardiac reflex.Timepoint: 1.5 years | — |
Countries
India
Contacts
Public ContactDr Nirupama Kasturi
Jawaharlal Institute of Postgraduate Medical Education and Research
Outcome results
None listed